STAT43%
Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer 68%
By Brittany Trang86%
7/20/2026, 10:59:00 AM
BS Summary: This article contains 20 faulty reasoning types, including Post Hoc (False Cause), Confirmation Bias, and Attempt to Sell a Product or Service, with Appeal to Authority as the most egregious example at 49.7% saturation with 80 hits. Analysis detected 707 faulty-reasoning hits from 161 analyzed words, generating a BS Score of 62.3% and a BS Rank of 68% (6,079 of 18,785 articles). This article is worse (more manipulative) than 67.60% of the article peer group.
It’s officially a trend.
For the third time in nine months, a pharma company has announced that it is assembling the largest AI supercomputer in the life sciences industry.
This time, it is Bristol Myers Squibb.
When the company began its partnership with NVIDIA three years ago with a smaller computing cluster, it was focusing on simpler problems with individual AI tools, like protein structure prediction.
But “we actually consumed all the space we had,” said Greg Meyers, chief digital & technology officer at BMS.
Adding extra computing power is necessary for the company now that it’s “become more convinced” that computationally hungry foundation models can give the company valuable insight into how its drug candidates interact with both the body and with disease, Meyers said in an interview with STAT.
He mentioned oncology and neurodegeneration as examples of areas where BMS has developed such models.
Analysis
Hover over highlighted words in the article to view the associated bias or fallacy analysis.